Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignancies.
Milo GattiCaterina CampoliTamara BelottiPier Giorgio CojuttiRiccardo MasettiAndrea PessionPierluigi VialeFederico PeaPublished in: Therapeutic drug monitoring (2022)
Our findings suggest that there is limited variability in isavuconazole exposure in hemato-oncological pediatric patients receiving azole prophylaxis , resulting in a low need for CPA-guided dosage adjustments.